PGRMC1 overexpression was further validated by analysing a panel of proprietary normal breast and breast cancer cell lines, which revealed high mRNA and protein levels of PGRMC1 in both ER-positive ZR-75-1 and TNBC MDA-MB-468 cell lines (Fig. 1f, g). This evidence concerns the gene PGRMC1 and breast carcinoma.